Following the analysis of the large data collection, 20 curated genes were identified as biomarkers or therapeutic candidates for COVID-19 therapy, including TMPRSS2 and CXCL10 (Supplementary Table 2). This evidence concerns the gene TMPRSS2 and COVID-19.